Biomarin Pharmaceutical Inc
Change company Symbol lookup
Select an option...
BMRN Biomarin Pharmaceutical Inc
CLPR Clipper Realty Inc
VGI Virtus Global Multi-Sector Income Fund
VDE Vanguard Energy Index Fund ETF Shares
VCV Invesco California Value Municipal Income Trust
VCSH Vanguard Short-Term Corporate Bond Index Fund ETF Shares
VBR Vanguard Small-Cap Value Index Fund ETF Shares
V Visa Inc
UPS United Parcel Service Inc
UNM Unum Group
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

BioMarin Pharmaceutical Inc. is a biotechnology company. The Company develops and commercializes pharmaceuticals for various diseases and medical conditions. As of December 31, 2016, the Company's therapy portfolio consisted of five products, and multiple clinical and pre-clinical product candidates. Its commercial products include Aldurazyme (laronidase) for Mucopolysaccharidosis I (MPS I), Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome (LEMS), Kuvan (sapropterin dihydrochloride) for phenylketonuria (PKU), Naglazyme (galsulfase) for Mucopolysaccharidosis VI (MPS VI) and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A (MPS IV A). The Company is conducting clinical trials on various product candidates for the treatment of various diseases. Its clinical product candidates include Brineura, pegvaliase, vosoritide, BMN 270 and BMN 250.

Premarket

Last Trade
Delayed
$128.10
2.26 (1.80%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$125.84
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
345

10-day average volume:
2,187,816
345
  • Prev Close
    125.84
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    2.2M
  • Last (time)
    4:00p ET 07/01/20
  • Last (size)
    90
  • 52-Wk Range
    62.88 - 128.77
    LowHigh
  • (10/02/19 - 07/01/20)
    2.28%
  • 43.2%
  • Market Cap
    22.8B
  • Shares Outstanding
    180.8M
  • 0.61
  • 206.15x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.1
  • 96.97
  • (% of float 06/15/20)
    5.48

Latest News

July 01, 2020
6:24 am ET
MarketWatch
June 23, 2020
8:30 am ET
PR Newswire
June 18, 2020
7:05 am ET
MarketWatch
June 17, 2020
4:05 pm ET
Globe Newswire
9:20 am ET
PR Newswire
June 05, 2020
7:14 pm ET
Globe Newswire
June 04, 2020
5:02 am ET
Globe Newswire
May 31, 2020
4:01 pm ET
PR Newswire
May 29, 2020
10:40 am ET
Zacks
May 19, 2020
4:15 pm ET
PR Newswire
May 11, 2020
11:26 pm ET
PR Newswire
7:16 am ET
PR Newswire
May 06, 2020
8:30 am ET
PR Newswire
April 17, 2020
7:00 am ET
Globe Newswire
April 06, 2020
8:31 am ET
PR Newswire
February 20, 2020
6:49 am ET
MarketWatch
January 28, 2020
9:15 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.